3SBio (TRSBF) Research & Development: $214 Mil (TTM As of Dec. 2025)


TRSBF 3SBio Inc TRSBF
90 GF Score
Price $2.15
GF Value $1.61
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is 3SBio Research & Development?

3SBio TRSBF -2.27% 90 Research & Development is $214 Mil as of Dec. 2025. GuruFocus rates TRSBF with a GF Score™ of 90/100 and a GF Value™ of $1.61 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. 3SBio's Research & Development for the six months ended in Dec. 2025 was $138 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $214 Mil.

3SBio  (OTCPK:TRSBF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

3SBio Research & Development Related Terms

3SBio Research & Development Historical Data

* Premium members only.

The historical data trend for 3SBio's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3SBio Research & Development Chart

3SBio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 118.36 99.52 111.31 182.20 215.86

3SBio Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.37 65.64 116.79 76.25 138.12
TRSBF
90GF Score
3SBio Inc TRSBF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

3SBio Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $214 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $214 Mil mean?
3SBio (TRSBF) has a Research & Development of $214 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on 3SBio and its competitors.
Is 3SBio's Research & Development too high?
3SBio's current Research & Development is $214 Mil. Overall, 3SBio has a GF Score™ of 90/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 3SBio's Research & Development compare to VRTX and REGN?
3SBio's Research & Development of $214 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on 3SBio and its competitors. 3SBio's current Research & Development is $214 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3SBio stock overvalued right now?
Based on GuruFocus' analysis, 3SBio (TRSBF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.61, compared to a current price of $2.15 — trading 33.5% above its estimated fair value. The current Research & Development is $214 Mil. 3SBio's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For 3SBio (TRSBF), the current Research & Development is $214 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 3SBio (TRSBF) Overvalued in 2026?

Based on GuruFocus' analysis, 3SBio stock appears to be overvalued. The current stock price of $2.15 is trading 33.5% above its estimated GF Value™ of $1.61. GuruFocus considers 3SBio to be Significantly Overvalued.

Key valuation signals for TRSBF:

  • Research & Development: $214 Mil
  • GF Value™: $1.61 vs. price of $2.15 (33.5% above fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the TRSBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

3SBio Business Description

Other Exchanges 01530:Hong Kong83B:Germany
Address No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN
3SBio Inc is an investment holding company. It is a primary biotechnology company. The company is principally engaged in the development, production, marketing and sale of biopharmaceutical products in the People's Republic of China. The group has only one operating segment. It has presence in Chinese mainland, USA, Other countries/regions. The majority of revenue comes from USA. The core commercialized products of the group include several bio-pharmaceutical drugs, namely, TPIAO, recombinant human erythropoietin (rhEPO) products EPIAO and SEPO, Yisaipu and Cipterbin, and a small molecule drug, Mandi series of minoxidil drugs.
90GF Score

Get the complete analysis for TRSBF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.15
Price
$1.61
GF Value